List of Tables
    Table 1. Chronic Obstructive Pulmonary Disorder Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Chronic Obstructive Pulmonary Disorder Market Trends
    Table 3. Chronic Obstructive Pulmonary Disorder Market Drivers
    Table 4. Chronic Obstructive Pulmonary Disorder Market Challenges
    Table 5. Chronic Obstructive Pulmonary Disorder Market Restraints
    Table 6. Global Chronic Obstructive Pulmonary Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Chronic Obstructive Pulmonary Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Chronic Obstructive Pulmonary Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Chronic Obstructive Pulmonary Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Chronic Obstructive Pulmonary Disorder Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Chronic Obstructive Pulmonary Disorder Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Player, 2017-2022
    Table 13. Global Chronic Obstructive Pulmonary Disorder Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Chronic Obstructive Pulmonary Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder as of 2021)
    Table 15. Top Players of Chronic Obstructive Pulmonary Disorder in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Chronic Obstructive Pulmonary Disorder Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Chronic Obstructive Pulmonary Disorder Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Chronic Obstructive Pulmonary Disorder Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Chronic Obstructive Pulmonary Disorder Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Chronic Obstructive Pulmonary Disorder Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Chronic Obstructive Pulmonary Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Chronic Obstructive Pulmonary Disorder Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Chronic Obstructive Pulmonary Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Chronic Obstructive Pulmonary Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Chronic Obstructive Pulmonary Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. GSK Company Details
    Table 31. GSK Business Overview
    Table 32. GSK Chronic Obstructive Pulmonary Disorder Product
    Table 33. GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 34. GSK Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Chronic Obstructive Pulmonary Disorder Product
    Table 38. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Chronic Obstructive Pulmonary Disorder Product
    Table 43. Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Chronic Obstructive Pulmonary Disorder Product
    Table 48. Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. AstraZeneca Company Details
    Table 51. AstraZeneca Business Overview
    Table 52. AstraZeneca Chronic Obstructive Pulmonary Disorder Product
    Table 53. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 54. AstraZeneca Recent Development
    Table 55. Boehringer Ingelheim Company Details
    Table 56. Boehringer Ingelheim Business Overview
    Table 57. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Product
    Table 58. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 59. Boehringer Ingelheim Recent Development
    Table 60. Teva Pharmaceuticals Company Details
    Table 61. Teva Pharmaceuticals Business Overview
    Table 62. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product
    Table 63. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 64. Teva Pharmaceuticals Recent Development
    Table 65. Ario Pharma Company Details
    Table 66. Ario Pharma Business Overview
    Table 67. Ario Pharma Chronic Obstructive Pulmonary Disorder Product
    Table 68. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 69. Ario Pharma Recent Development
    Table 70. Roche Company Details
    Table 71. Roche Business Overview
    Table 72. Roche Chronic Obstructive Pulmonary Disorder Product
    Table 73. Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 74. Roche Recent Development
    Table 75. Ache Company Details
    Table 76. Ache Business Overview
    Table 77. Ache Chronic Obstructive Pulmonary Disorder Product
    Table 78. Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 79. Ache Recent Development
    Table 80. Almirall Company Details
    Table 81. Almirall Business Overview
    Table 82. Almirall Chronic Obstructive Pulmonary Disorder Product
    Table 83. Almirall Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 84. Almirall Recent Development
    Table 85. Aquinox Pharmaceuticals Company Details
    Table 86. Aquinox Pharmaceuticals Business Overview
    Table 87. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product
    Table 88. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 89. Aquinox Pharmaceuticals Recent Development
    Table 90. Asmacure Company Details
    Table 91. Asmacure Business Overview
    Table 92. Asmacure Chronic Obstructive Pulmonary Disorder Product
    Table 93. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 94. Asmacure Recent Development
    Table 95. Astellas Pharma Company Details
    Table 96. Astellas Pharma Business Overview
    Table 97. Astellas Pharma Chronic Obstructive Pulmonary Disorder Product
    Table 98. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 99. Astellas Pharma Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chronic Obstructive Pulmonary Disorder Product Picture
    Figure 2. Global Chronic Obstructive Pulmonary Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Chronic Obstructive Pulmonary Disorder Market Size 2017-2028 (US$ Million)
    Figure 4. United States Chronic Obstructive Pulmonary Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Chronic Obstructive Pulmonary Disorder Market Size 2017-2028 (US$ Million)
    Figure 6. United States Chronic Obstructive Pulmonary Disorder Market Share in Global 2017-2028
    Figure 7. Chronic Obstructive Pulmonary Disorder Report Years Considered
    Figure 8. Product Picture of Short-Acting Bronchodilators
    Figure 9. Product Picture of Corticosteroids
    Figure 10. Product Picture of Methylxanthines
    Figure 11. Product Picture of Long-Acting Bronchodilators
    Figure 12. Product Picture of Phosphodiesterase-4 Inhibitors
    Figure 13. Product Picture of Others
    Figure 14. Global Chronic Obstructive Pulmonary Disorder Market Share by Type in 2022 & 2028
    Figure 15. Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    Figure 17. United States Chronic Obstructive Pulmonary Disorder Market Share by Type in 2022 & 2028
    Figure 18. United States Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Others
    Figure 23. Global Chronic Obstructive Pulmonary Disorder Market Share by Application in 2022 & 2028
    Figure 24. Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    Figure 26. United States Chronic Obstructive Pulmonary Disorder Market Share by Application in 2022 & 2028
    Figure 27. United States Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    Figure 29. North America Chronic Obstructive Pulmonary Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Chronic Obstructive Pulmonary Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Chronic Obstructive Pulmonary Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. UAE Chronic Obstructive Pulmonary Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 62. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 64. Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 65. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 66. Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 67. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 68. Aquinox Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 69. Asmacure Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 70. Astellas Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed